close

Board of Directors (BOD) Committees

BOD Committees

General Meeting of Shareholders

13th General Meeting of Shareholders

1. Date : March 15, 2024 (9:00 a.m. KST)

2. Venue : Songdo Convensia 1F, Room No. 113 (123, Central-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Report on Related Party Transactions
  2. - Report on Audit by Audit Committee
  3. - Report on Business
  4. - Report on Internal Audit Management
· Matters to Approve
  1. - Approval of FY2023 Consolidated Financial Statements
  2. - Appointment of Independent Director : Seoung-hwan Suh (Newly-nominated)
  3. - Appointment of Audit Committee Member : Seoung-hwan Suh (Newly-nominated)
  4. - Approval of Director Remuneration Limit (FY2024)
12th General Meeting of Shareholders

1. Date : March 17, 2023 (9:00 a.m. KST)

2. Venue : Samsung Biologics, Global Hall (300, Songdo bio-daero, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Report on Related Party Transactions
  2. - Report on Audit by Audit Committee
  3. - Report on Business
  4. - Report on Internal Audit Management
· Matters to Approve
  1. - Approval of FY2022 Consolidated Financial Statements
  2. - Appointment of Directors
    • : Appointment of Executive Director : John Rim (Reappointment)
    • : Appointment of Executive Director : Kun Lo (Newly-nominated)
    • : Appointment of Independent Director : Eunice Kyonghee Kim (Reappointment)
    • : Appointment of Independent Director : Dogeol Ahn (Newly-nominated)
  3. - Appointment of Audit Committee Member
    • : Appointment of Independent Director : Dogeol Ahn (Newly-nominated)
  4. - Approval of Director Remuneration Limit (FY2023)

Results of 12th General Meeting of Shareholders

(Shares present: 64,973,539)

Results of 11th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of FY2022 Consolidated Financial Statements Approved 98.53%
Agenda #2 Appointment of Directors
Agenda #2-1 Appointment of Executive Director : John Rim (Reappointment) Approved 99.93%
Agenda #2-2 Appointment of Executive Director : Kun Lo (Newly-nominated) Approved 99.89%
Agenda #2-3 Appointment of Independent Director : Eunice Kyonghee Kim (Reappointment) Approved 96.47%
Agenda #2-4 Appointment of Independent Director : Dogeol Ahn (Newly-nominated) Approved 99.94%
Agenda #3 Appointment of Director as Audit Committee Member Appointment of Independent Director : Dogeol Ahn (Newly-nominated) Approved 99.72%
Agenda #4 Approval of Director Remuneration Limit (FY2023) Approved 99.55%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis

11th General Meeting of Shareholders

1. Date : March 29, 2022 (9:00 a.m. KST)

2. Venue : Incheon Global Campus Auditorium (119, Songdomunhwa-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Related Party Transactions Report
  2. - Audit Report
  3. - Business Report
  4. - Internal Audit Management Report
· Matters to Approve
  1. - Approval of Financial Statement (FY 2021)
  2. - Appointment of Directors
    • : Appointment of Inside Director: Mr. Dong Joong Kim (Re-nominated)
    • : Appointment of Outside(Independent) Director: Mr. Kun Nyoung Huh (Re-nominated)
    • : Appointment of Outside(Independent) Director:: Mr. Jae Wan Bahk (Newly-nominated)
  3. -Appointment of Director as Audit Committee Member
    • : Appointment of Outside(Independent) Director: Mr. Chang Woo Lee (Newly-nominated)
  4. - Appointment of Audit Committee Member
    • : Appointment of Outside(Independent) Director: Mr. Kun Nyoung Huh (Re-nominated)
    • : Appointment of Outside(Independent) Director: Ms. Eunice Kyonghee KIM (New-ly nominated)
  5. - Approval of the Remuneration Limit for the Directors (FY 2022)

Results of 11th General Meeting of Shareholders

(Shares present: 61,018,228)

Results of 11th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of Financial Statement (FY 2021) Approved 99.90%
Agenda #2 Appointment of Directors
Agenda #2-1 Appointment of Inside Director: Mr. Dong Joong Kim (Re-nominated) Approved 86.41%
Agenda #2-2 Appointment of Outside(Independent) Director: Mr. Kun Nyoung Huh (Re-nominated) Approved 93.36%
Agenda #2-3 Appointment of Outside(Independent) Director:: Mr. Jae Wan Bahk (Newly-nominated) Approved 87.05%
Agenda #3 Appointment of Director as Audit Committee Member Appointment of Outside(Independent) Director: Mr. Chang Woo Lee (Newly-nominated) Approved 99.79%
Agenda #4 Appointment of Audit Committee Member
Agenda #4-1 Appointment of Outside(Independent) Director: Mr. Kun Nyoung Huh (Re-nominated) Approved 69.50%
Agenda #4-2 Appointment of Outside(Independent) Director: Ms. Eunice Kyonghee KIM (New-ly nominated) Approved 80.26%
Agenda #5 Approval of the Remuneration Limit for the Directors (FY 2021) Approved 93.07%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis

10th General Meeting of Shareholders

1. Date : March 19, 2021 (9:00 a.m. KST)

2. Venue : Incheon Global Campus Auditorium (119, Songdomunhwa-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Related Party Transactions Report
  2. - Audit Report
  3. - Business Report
  4. - Internal Audit Management Report
· Matters to Approve
  1. - Approval of Financial Statement (FY 2020)
  2. - Approval of the Remuneration Limit for the Directors (FY 2021)

Results of 10th General Meeting of Shareholders

(Shares present: 58,696,074)

Results of 10th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of Financial Statement(FY2020) Approved 99.06%
Agenda #2 Approval of the Remuneration Limit for the Directors(FY2021) Approved 92.95%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis.

9th General Meeting of Shareholders

1. Date : March 20, 2020 (9:00 a.m. KST)

2. Venue : Incheon Global Campus Auditorium (119, Songdomunhwa-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Related Party Transactions Report
  2. - Adjustment to Financial Statements
  3. - Audit Report
  4. - Business Report
  5. - Internal Audit Management Report
· Matters to Approve
  1. - Approval of Audited Financial Statement(FY2019)
  2. - Appointment of Directors
    • : Appointment of Inside Director: Mr. Tae Han Kim
    • : Appointment of Inside Director: Mr. John Rim
    • : Appointment of Outside(Independent) Director: Ms. Eunice Kyounghee Kim
  3. - Approval of the Remuneration Limit for the Directors (FY 2020)

Results of 9th General Meeting of Shareholders

(Shares present : 58,112,757)

Results of 9th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of Audited Financial Statement(FY2019) Approved 95.05%
Agenda #2 Appointment of Directors
Agenda #2-1 Appointment of Inside Director: Mr. Tae Han Kim Approved 91.54%
Agenda #2-2 Appointment of Inside Director: Mr. John Rim Approved 94.19%
Agenda #2-3 Appointment of Outside(Independent) Director: Ms. Eunice Kyounghee Kim Approved 99.99%
Agenda #3 Approval of the Remuneration Limit for the Directors(FY2020) Approved 93.09%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis.

8th General Meeting of Shareholders

1. Date : March 22, 2019 (9:00 a.m. KST)

2. Venue : Incheon Global Campus Auditorium (119, Songdomunhwa-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Related Person Transaction Report
  2. - Audit Report
  3. - Business Report
  4. - Internal Accounting Control System Report
· Matters to Approve
  1. - Approval of Financial Statement (FY 2018)
  2. - Some changes of Articles of Incorporation
  3. - Appointment of Directors
    • : Appointment of Inside Director: Mr. Dong Joong Kim
    • : Appointment of Outside(Independent) Director: Mr. Seok Woo Jeong
    • : Appointment of Outside(Independent) Director: Mr. Soon Jo Kwon
    • : Appointment of Outside(Independent) Director: Mr. Ken Nyoung Huh
  4. - Appointment of Member of Audit Committee
    • : Appointment of Outside(Independent) Director: Mr. Seok Woo Jeong
    • : Appointment of Outside(Independent) Director: Mr. Soon Jo Kwon
    • : Appointment of Outside(Independent) Director: Mr. Ken Nyoung Huh
  5. - Approval of the Remuneration Limit for the Directors (FY 2019)

Results of 8th General Meeting of Shareholders

(Shares present : 57,749,293)

Results of 6th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of Financial Statement(FY2018) Approved 91.72%
Agenda #2 Some changes of Articles of Incorporation Approved 99.97%
Agenda #3 Appointment of Directors
Agenda #3-1 Appointment of Inside Director: Mr. Dong Joong Kim Approved 90.62%
Agenda #3-2 Appointment of Outside(Independent) Director: Mr. Seok Woo Jeong Approved 91.11%
Agenda #3-3 Appointment of Outside(Independent) Director: Mr. Soon Jo Kwon Approved 91.11%
Agenda #3-4 Appointment of Outside(Independent) Director: Mr. Ken Nyoung Huh Approved 99.97%
Agenda #4 Appointment of Member of Audit Committee
Agenda #4-1 Appointment of Audit Committee: Mr. Seok Woo Jeong Approved 57.23%
Agenda #4-2 Appointment of Audit Committee: Mr. Soon Jo Kwon Approved 57.26%
Agenda #4-3 Appointment of Audit Committee: Mr. Ken Nyoung Huh Approved 99.85%
Agenda #5 Approval of the Remuneration Limit for the Directors(FY2019) Approved 96.40%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis.

7th General Meeting of Shareholders

1. Date : March 22, 2018, AM 9 (KST)

2. Venue : Incheon Global Campus Auditorium (119, Songdomunhwa-ro, Yeonsu-gu, Incheon, Republic of Korea)

3. Agenda

· Matters to Report
  1. - Related Person Transaction Report
  2. - Audit Report
  3. - Business Report
· Matters to Approve
  1. - Approval of Financial Statements (FY 2017)
  2. - Approval of the Remuneration Limit for the Directors (FY 2018)

Results of 7th General Meeting of Shareholders

(Shares present : 57,797,534)

Results of 6th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result Approval Rate
Agenda #1 Approval of Financial Statement (FY 2017) Approved 99.66%
Agenda #2 Approval of the Remuneration Limit for the Directors (FY 2018) Approved 93.17%

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis.

6th General Meeting of Shareholders

Agenda 1
: Approval of Financial Statement (FY 2016)

Agenda 2
: Election of Board Member

  • · Internal Director Tae Han Kim

Agenda 3
: Approval of the Remuneration Limit for the Directors (FY 2017)

  • · Total Remuneration : KRW 9.5 billion

Results of 6th General Meeting of Shareholders

(Shares present : 58,596,329)

Results of 6th General Meeting of Shareholders - Agenda, Approval Rate
Agenda Result
Agenda #1 Approval of Financial Statement (FY 2016) Approved
Agenda #2 Election of Internal Director Approved
Agenda #3 Approval of the Remuneration Limit for the Directors (FY 2017) Approved

※ Shares present : Total number of the common shares with voting rights represented at the opening of the Meeting basis.

Rights to present shareholder proposals

In accordance with Article 542-6 of the Commercial Code, shareholders who own more than 3.0% of outstanding shares with voting rights, or shareholders who own more than 1.0% of outstanding shares with voting rights for more than six months may present shareholder proposals, e.g., director appointments, as agenda items at the Annual General Meeting of Shareholders, in paper or electronic document form within six weeks prior to the AGM.

The Board shall accept the proposal as an agenda item for a general meeting of shareholders, except where such proposal is in violation of laws or the articles of incorporation, or where it is subject to the rejection of a shareholder proposal as stipulated in Article 12 of the Enforcement Degree of the Commercial Code.

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION